IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+5.25%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$358M
AUM Growth
+$358M
(+11%)
Cap. Flow
+$30.7M
Cap. Flow
% of AUM
8.56%
Top 10 Holdings %
Top 10 Hldgs %
49.91%
Holding
70
New
7
Increased
17
Reduced
7
Closed
6
Top Buys
| 1 |
Amgen
AMGN
|
$18.1M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$10.4M |
| 3 |
Harmony Biosciences
HRMY
|
$9.99M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$6.88M |
| 5 |
Vera Therapeutics
VERA
|
$5.57M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$35.8M |
| 2 |
Travere Therapeutics
TVTX
|
$5.35M |
| 3 |
Illumina
ILMN
|
$4.65M |
| 4 |
uniQure
QURE
|
$3.08M |
| 5 |
PTC Therapeutics
PTCT
|
$2.47M |
Sector Composition
| 1 | Healthcare | 99.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
| $40.5M | 11.3% | 200,200 +34,000 | +20% | +$6.88M |
|
|
2
Amgen
AMGN
$155B
| $22.1M | 6.15% | 91,246 +75,000 | +462% | +$18.1M |
|
3
Incyte
INCY
$16.5B
| $20.2M | 5.63% | 279,000 +50,000 | +22% | +$3.61M |
|
|
4
Harmony Biosciences
HRMY
$2.12B
| $18.6M | 5.2% | 570,500 +306,000 | +116% | +$9.99M |
|
5
Alkermes
ALKS
$4.78B
| $16.7M | 4.66% | 593,000 | – | – |
|
6
Supernus Pharmaceuticals
SUPN
$2.53B
| $15.3M | 4.28% | 423,500 +40,000 | +10% | +$1.45M |
|
|
ITCI
7
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $14M | 3.89% | 257,856 +36,000 | +16% | +$1.95M |
|
8
Ultragenyx Pharmaceutical
RARE
$2.89B
| $10.6M | 2.95% | 264,052 +90,000 | +52% | +$3.61M |
|
9
Exelixis
EXEL
$10.1B
| $10.5M | 2.94% | 543,000 | – | – |
|
|
10
Vertex Pharmaceuticals
VRTX
$100B
| $10.4M | 2.9% | +33,000 | New | +$10.4M |
|
|
11
uniQure
QURE
$896M
| $9.64M | 2.69% | 478,500 -153,000 | -24% | -$3.08M |
|
12
Alnylam Pharmaceuticals
ALNY
$58.5B
| $9.33M | 2.6% | 46,600 +8,600 | +23% | +$1.72M |
|
13
Regeneron Pharmaceuticals
REGN
$61.5B
| $9.2M | 2.57% | 11,200 | – | – |
|
|
MRTX
14
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.07M | 2.53% | 244,000 | – | – |
|
15
Sanofi
SNY
$121B
| $7.81M | 2.18% | 143,500 | – | – |
|
|
16
Vera Therapeutics
VERA
$1.38B
| $7.75M | 2.16% | 1,002,257 +721,000 | +256% | +$5.57M |
|
|
KDNY
17
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $7.41M | 2.07% | 319,989 -20,400 | -6% | -$472K |
|
18
United Therapeutics
UTHR
$13.8B
| $6.38M | 1.78% | 28,500 +13,500 | +90% | +$3.02M |
|
19
Aurinia Pharmaceuticals
AUPH
$1.58B
| $6.28M | 1.75% | 573,530 | – | – |
|
|
20
Illumina
ILMN
$15.8B
| $6.16M | 1.72% | 26,500 -20,000 | -43% | -$4.65M |
|
21
Biogen
BIIB
$19.4B
| $5.95M | 1.66% | 21,400 | – | – |
|
|
RVNC
22
DELISTED
Revance Therapeutics, Inc.
RVNC
| $5.89M | 1.64% | 183,000 +63,000 | +53% | +$2.03M |
|
23
BioMarin Pharmaceuticals
BMRN
$11.2B
| $5.7M | 1.59% | 58,656 +15,000 | +34% | +$1.46M |
|
24
Dyne Therapeutics
DYN
$1.92B
| $4.99M | 1.39% | 433,751 -207,317 | -32% | -$2.38M |
|
|
ONC
25
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $4.89M | 1.37% | 22,700 +7,000 | +45% | +$1.51M |
|